Kovitz Investment Group Partners LLC lifted its stake in shares of Koninklijke Philips N.V. (NYSE:PHG - Free Report) by 110.9% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 76,054 shares of the technology company's stock after purchasing an additional 39,998 shares during the period. Kovitz Investment Group Partners LLC's holdings in Koninklijke Philips were worth $1,932,000 at the end of the most recent quarter.
Other hedge funds have also made changes to their positions in the company. Northern Trust Corp lifted its stake in Koninklijke Philips by 36.6% in the 4th quarter. Northern Trust Corp now owns 1,608,749 shares of the technology company's stock worth $40,734,000 after acquiring an additional 430,757 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of Koninklijke Philips by 3,094.8% during the 1st quarter. GAMMA Investing LLC now owns 350,241 shares of the technology company's stock worth $8,896,000 after acquiring an additional 339,278 shares in the last quarter. Hsbc Holdings PLC acquired a new position in Koninklijke Philips during the fourth quarter valued at approximately $3,039,000. Timber Creek Capital Management LLC raised its holdings in Koninklijke Philips by 512.5% in the 1st quarter. Timber Creek Capital Management LLC now owns 105,185 shares of the technology company's stock worth $2,672,000 after acquiring an additional 88,012 shares during the period. Finally, Dimensional Fund Advisors LP grew its position in shares of Koninklijke Philips by 2.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 4,290,051 shares of the technology company's stock valued at $108,624,000 after purchasing an additional 85,994 shares during the last quarter. Hedge funds and other institutional investors own 13.67% of the company's stock.
Analyst Ratings Changes
Separately, Wall Street Zen cut Koninklijke Philips from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Buy".
Get Our Latest Stock Analysis on Koninklijke Philips
Koninklijke Philips Price Performance
NYSE:PHG traded up $0.8750 during mid-day trading on Friday, hitting $28.3150. The company's stock had a trading volume of 835,595 shares, compared to its average volume of 1,158,058. The stock has a fifty day moving average of $25.22 and a 200-day moving average of $24.99. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $27.27 billion, a price-to-earnings ratio of 149.03, a P/E/G ratio of 0.77 and a beta of 0.75. Koninklijke Philips N.V. has a fifty-two week low of $21.48 and a fifty-two week high of $32.91.
Koninklijke Philips (NYSE:PHG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The technology company reported $0.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.29 by $0.12. Koninklijke Philips had a return on equity of 11.95% and a net margin of 1.00%.The company had revenue of $5.05 billion during the quarter, compared to analysts' expectations of $4.35 billion. As a group, equities analysts forecast that Koninklijke Philips N.V. will post 1.63 EPS for the current fiscal year.
About Koninklijke Philips
(
Free Report)
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Featured Stories

Before you consider Koninklijke Philips, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Koninklijke Philips wasn't on the list.
While Koninklijke Philips currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.